J&J Will Pay $120M To Settle State Hip Claims
Executive Summary
Johnson & Johnson will pay $120m to settle allegations the company misled consumers about metal-on-metal hip implants under an agreement reached with 46 state attorneys general.
You may also be interested in...
Patients Awarded $1bn In J&J Ultamet Hip Lawsuit
The bellwether case resulted in a jury award of $1b to a group of six California patients who say they were injured by the metal-on-metal hip. J&J plans to appeal.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.